Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-12-01 Sale | 2022-12-02 5:14 pm | Passage BIO Inc. | PASG | Kapadia Sandip Director | 5,000 | $1.1929 | $5,965 | 0 (Direct) | View |
2022-11-22 Sale | 2022-11-25 4:15 pm | Passage BIO Inc. | PASG | Fotopoulos Alexandros Chief Technical Officer | 3,720 | $1.33 | $4,948 | 57,745 (Direct) | View |
2022-09-15 Sale | 2022-11-18 5:01 pm | Passage BIO Inc. | PASG | Toernsen Monika Maria Chief Commercial Officer | 1,681 | $1.5105 | $2,539 | 18,319 (Direct) | View |
2022-05-03 Purchase | 2022-05-05 5:23 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 525,000 | $1.9358 | $1,016,285 | 6,841,423 (Indirect) | View |
2022-01-20 Purchase(A) | 2022-05-05 5:11 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 50,800 | $5 | $254,000 | 6,316,423 (Indirect) | View |
2022-03-21 Purchase | 2022-03-23 4:43 pm | Passage BIO Inc. | PASG | Goldsmith Bruce A CEO and President | 10,000 | $3.15 | $31,500 | 15,983 (Direct) | View |
2022-01-20 Purchase | 2022-01-24 4:44 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 369,100 | $5.42 | $2,000,522 | 6,634,723 (Indirect) | View |
2022-01-14 Purchase | 2022-01-20 6:03 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 168,300 | $5.3785 | $905,205 | 6,265,623 (Indirect) | View |
2022-01-11 Purchase | 2022-01-13 7:37 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 150,000 | $5.6072 | $841,082 | 6,097,323 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-11-22 Exercise | 2022-11-25 4:15 pm | N/A N/A | Passage BIO Inc. | PASG | Fotopoulos Alexandros Chief Technical Officer | 12,500 | $0 | 57,745 (Direct) | View |
2022-09-15 Exercise | 2022-11-18 5:01 pm | N/A 2031-07-18 | Passage BIO Inc. | PASG | Toernsen Monika Maria Chief Commercial Officer | 5,000 | $0 | 18,319 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 4:23 pm | N/A N/A | Passage BIO Inc. | PASG | King Simona Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 4:22 pm | N/A N/A | Passage BIO Inc. | PASG | Forman Mark S Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 4:22 pm | N/A N/A | Passage BIO Inc. | PASG | Cale Edgar B. GC & Corporate Secretary | 50,000 | $0 | 50,000 (Direct) | View |
2022-11-10 Option Award | 2022-11-14 4:21 pm | N/A N/A | Passage BIO Inc. | PASG | Fotopoulos Alexandros Chief Technical Officer | 50,000 | $0 | 50,000 (Direct) | View |
2022-10-10 Option Award | 2022-10-12 4:08 pm | N/A 2032-10-09 | Passage BIO Inc. | PASG | Chou William Chief Executive Officer | 885,000 | $0 | 885,000 (Direct) | View |
2022-07-05 Option Award | 2022-07-06 8:32 pm | N/A 2032-07-04 | Passage BIO Inc. | PASG | Kamarck Michael E. Director | 48,000 | $0 | 48,000 (Direct) | View |
2022-06-13 Option Award | 2022-06-15 5:33 pm | N/A 2032-06-12 | Passage BIO Inc. | PASG | Toernsen Monika Maria Chief Commercial Officer | 101,000 | $0 | 101,000 (Direct) | View |
2022-06-13 Option Award | 2022-06-15 5:25 pm | N/A 2032-06-12 | Passage BIO Inc. | PASG | King Simona Chief Financial Officer | 159,000 | $0 | 159,000 (Direct) | View |
2022-06-13 Option Award | 2022-06-15 5:24 pm | N/A 2032-06-12 | Passage BIO Inc. | PASG | Forman Mark S Chief Medical Officer | 136,000 | $0 | 136,000 (Direct) | View |
2022-06-13 Option Award | 2022-06-15 5:22 pm | N/A 2032-06-12 | Passage BIO Inc. | PASG | Cale Edgar B. Interim CEO GC & Corp. Sec. | 106,000 | $0 | 106,000 (Direct) | View |
2022-06-13 Option Award | 2022-06-15 5:21 pm | N/A 2032-06-12 | Passage BIO Inc. | PASG | Fotopoulos Alexandros Chief Technical Officer | 200,000 | $0 | 200,000 (Direct) | View |
2022-05-31 Option Award | 2022-06-01 4:27 pm | N/A 2032-05-30 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 40,000 | $0 | 40,000 (Direct) | View |
2022-05-27 Option Award | 2022-06-01 4:25 pm | N/A 2032-05-26 | Passage BIO Inc. | PASG | Goldsmith Bruce A CEO and President | 100,000 | $0 | 100,000 (Direct) | View |
2022-05-31 Option Award | 2022-06-01 4:17 pm | N/A 2032-05-30 | Passage BIO Inc. | PASG | Cale Edgar B. Interim CEO GC & Corp. Sec. | 100,000 | $0 | 100,000 (Direct) | View |
2022-05-26 Option Award | 2022-05-31 4:33 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 24,000 | $0 | 24,000 (Direct) | View |
2022-05-26 Option Award | 2022-05-31 4:32 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | Porter Derrell Director | 24,000 | $0 | 24,000 (Direct) | View |
2022-05-26 Option Award | 2022-05-31 4:28 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | Kapadia Sandip Director | 24,000 | $0 | 24,000 (Direct) | View |
2022-05-26 Option Award | 2022-05-31 4:25 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | Islam Saqib Director | 24,000 | $0 | 24,000 (Direct) | View |
2022-05-26 Option Award | 2022-05-31 4:22 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | GOWEN MAXINE Director | 24,000 | $0 | 24,000 (Direct) | View |
2022-05-26 Option Award | 2022-05-31 4:20 pm | N/A 2032-05-25 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 24,000 | $0 | 24,000 (Direct) | View |
2022-04-18 Option Award | 2022-04-20 4:23 pm | N/A N/A | Passage BIO Inc. | PASG | King Simona Chief Financial Officer | 25,000 | $0 | 25,000 (Direct) | View |
2022-04-18 Option Award | 2022-04-20 4:22 pm | N/A 2032-04-17 | Passage BIO Inc. | PASG | Forman Mark S Chief Medical Officer | 136,000 | $0 | 136,000 (Direct) | View |
2022-02-10 Option Award | 2022-02-14 5:27 pm | N/A 2032-02-09 | Passage BIO Inc. | PASG | Toernsen Monika Maria Chief Commercial Officer | 101,000 | $0 | 101,000 (Direct) | View |
2022-02-10 Option Award | 2022-02-14 5:21 pm | N/A 2032-02-09 | Passage BIO Inc. | PASG | Salinas Eliseo Oreste Chief Res. & Develop Officer | 157,500 | $0 | 157,500 (Direct) | View |
2022-02-10 Option Award | 2022-02-14 5:14 pm | N/A 2032-02-09 | Passage BIO Inc. | PASG | Fotopoulos Alexandros Chief Technical Officer | 163,900 | $0 | 172,283 (Direct) | View |
2022-02-10 Option Award | 2022-02-14 5:05 pm | N/A 2032-02-09 | Passage BIO Inc. | PASG | King Simona Chief Financial Officer | 159,000 | $0 | 159,000 (Direct) | View |
2022-02-10 Option Award | 2022-02-14 4:57 pm | N/A 2032-02-09 | Passage BIO Inc. | PASG | Goldsmith Bruce A CEO and President | 400,000 | $0 | 400,000 (Direct) | View |
2022-02-10 Option Award | 2022-02-14 4:47 pm | N/A 2032-02-09 | Passage BIO Inc. | PASG | Cale Edgar B. GC and Corporate Secretary | 106,000 | $0 | 110,759 (Direct) | View |